Streetwise
Lauren Rudd
Sunday, April 12,
2009
Time To Step Up To The Bar
If you have not already done so, now is time to step up the
bar and take responsibility for your financial future. Yes, Wall Street has been
volatile of late and the major players have shown little inclination to do
anything but line their own pockets and the rest of the world be damned.
Not to ruin your day but the financial markets have always
been driven by greed, as are most markets. Furthermore, the wealthiest are often
the greediest. This is no sudden epiphany; it has been so throughout history.
Technology and time have merely changed the way and speed with which we do
business, not the seemingly insatiable desire for ever increasing amounts of
wealth.
However, the Street’s antics should not be an impediment to
your investment decisions. When you invest in individual stocks you are not
buying the market; or Wall Street or the continually touted Dow Jones industrial
average. Instead, you are creating partnerships with approximately 12-15 high
quality companies whose projected future success coincides with your analysis of
their prospects.
Selecting candidates is not rocket science. If you have the
wherewithal to be able to write your name and address and can use a telephone or
a computer then you are already half-way there. Now all that is left is to steer
your search in the direction of large, dividend paying, blue chip companies. And
it is especially helpful if they are under appreciated. A good example is
Monsanto (MON), a company not mentioned here for two years. Meanwhile, Monsanto
has provided shareholders with a 14 percent return year-to-date and an 86
percent return over the past three years.
For its 2009 fiscal second quarter, Monsanto reported sales
of $4 billion, an 8 percent increase over the same period a year ago. Key
drivers were corn and soybean seeds and the company’s traits businesses. A drop
in Roundup herbicide sales did hurt results a bit. However, Roundup revenues
normally rise during the third and fourth quarters. For the first half of its
fiscal year, Monsanto chalked up $6.7 billion in sales, a 16 percent increase
when compared to a year ago and a new company record.
Net income for the quarter was a shade light at $1.1 billion,
a decrease of 3 percent when compared to a year ago. However, for the 6 month
period, Monsanto’s net income rose 19 percent to $1.6 billion.
Earnings per share for the second quarter came in at $1.97,
while for the six months the number was $2.96. Free cash flow for the first half
of the fiscal year totaled $1.1 billion, as compared to 1.5 billion for the same
period a year ago. The improvement in earnings was offset somewhat by higher
inventory levels. Nonetheless, Monsanto’s earnings guidance for the 2009 fiscal
year is $4.23 to $4.33 per share, with free cash flow of about $1.8 billion.
Calculating the intrinsic value of the shares, using a
discounted earnings approach and an earnings number of $2 billion, along with an
earnings growth rate of 15 percent and a discount rate of 15 percent, results in
a net present value for the company's next 10 years of earnings of $20.24
billion.
For earnings beyond the 10th year, I used a growth rate of 6
percent and a discount rate of 12 percent. The result is a continuing value of
$35.76 billion. Add those two figures together, subtract long-term debt of
$170.40 billion and divide by the outstanding shares (545.8 million). The result
is a per share intrinsic value of $99.47.
The more conservative free cash flow to the firm model from ValuePro.net, using
a 15 percent earnings growth rate, suggests an intrinsic value of $108. The
shares recently closed at $80.20. My earnings estimate for Monsanto for this
fiscal year is $4.70 per share with a 12-month target price on the shares of
$92. The result is a potential capital gain of 14.7 percent plus a dividend
yield of 1.3 percent.